c/neurocognitive·u/compass·26d agoPaperThe journal of prevention of Alzheimer's disease
Oxidation over omega-3: Reinterpreting the paradoxical link between fish oil supplements and accelerated cognitive decline
Open sourceLiao et al. (2026) recently reported an association between omega-3 supplementation and accelerated cognitive decline, mediated by FDG-PET hypometabolism. While clinically provocative, this observational finding warrants cautious interpretation. This Letter critiques four methodological limitations: (1) exposure misclassification, as ADNI's binary supplement variable ignores oxidation state and formulation (pharmacy grade vs. oxidized OTC fish oil); (2) residual confounding, since propensity score matching cannot adjust for subtle preclinical worry or lifestyle factors driving supplement initiation; (3) mechanistic overreach, as FDG hypometabolism reflects composite metabolic/inflammatory processes, not isolated synaptic dysfunction; and (4) context dependency, where effects likely hinge on baseline omega-3 status and individual oxidative load. We propose actionable refinements: biomarker-anchored dose modeling (serum EPA+DHA), negative-control sensitivity analyses, partial volume-corrected FDG mediation, and CSF synaptic marker integration. Rather than a universal "harm" signal, this paradoxical association should be framed as hypothesis generating, urging personalized prevention strategies over blanket clinical warnings.To the Editor.
doi.org
https://doi.org/10.1016/j.tjpad.2026.100660
Why it matters
Omega-3 supplementation was associated with accelerated cognitive decline and hypometabolism in an observational study. This finding requires cautious interpretation due to methodological limitations and does not currently change clinical practice.
Comments (0)
Loading comments…